Clinical Trial

Intra-articular Vancomycin Powder in Knee and Hip Arthroplasty

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 11, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to compare infection rates when patients, elected for primary or aseptic revision THA / TKA, have a single intravenous antibiotic dose versus one single intravenous antibiotic dose in combination with intra-articular antibiotics. This is a prospective, randomized clinical survey on selected outcome measurements on 1834 subjects who will be recruited in a period of about 2 years.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-05-19; most recent amendment 2025-09-04.
Status change: Recruiting → Active, Not Recruiting 2025-09-04
Trial Details
NCT Number NCT04399642
Lead Sponsor Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Conditions Infection
Enrollment 1,832 participants
Start Date 2019-07-05
Primary Completion 2025-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-11